Eric Plitman, L. Venkatraghavan, Sanket Agrawal, Vishvak Raghavan, Tumul Chowdhury, O. Sobczyk, E. Sayin, J. Poublanc, James Duffin, David D. Mikulis, J. Fisher
{"title":"Variability of Resting Carbon Dioxide Tension in Patients with Intracranial Steno-occlusive Disease","authors":"Eric Plitman, L. Venkatraghavan, Sanket Agrawal, Vishvak Raghavan, Tumul Chowdhury, O. Sobczyk, E. Sayin, J. Poublanc, James Duffin, David D. Mikulis, J. Fisher","doi":"10.1055/s-0044-1786699","DOIUrl":null,"url":null,"abstract":"Abstract Introduction Controlling the partial pressure of carbon dioxide (PaCO 2 ) is an important consideration in patients with intracranial steno-occlusive disease to avoid reductions in critical perfusion from vasoconstriction due to hypocapnia, or reductions in blood flow due to steal physiology during hypercapnia. However, the normal range for resting PCO 2 in this patient population is not known. Therefore, we investigated the variability in resting end-tidal PCO 2 (P ET CO 2 ) in patients with intracranial steno-occlusive disease and the impact of revascularization on resting P ET CO 2 in these patients. Setting and Design Tertiary care center, retrospective chart review Materials and Methods We collected resting P ET CO 2 values in adult patients with intracranial steno-occlusive disease who presented to our institution between January 2010 and June 2021. We also explored postrevascularization changes in resting P ET CO 2 in a subset of patients. Results Two hundred and twenty-seven patients were included [moyamoya vasculopathy ( n = 98) and intracranial atherosclerotic disease ( n = 129)]. In the whole cohort, mean ± standard deviation resting P ET CO 2 was 37.8 ± 3.9 mm Hg (range: 26–47). In patients with moyamoya vasculopathy and intracranial atherosclerotic disease, resting P ET CO 2 was 38.4 ± 3.6 mm Hg (range: 28–47) and 37.4 ± 4.1 mm Hg (range: 26–46), respectively. A trend was identified suggesting increasing resting P ET CO 2 after revascularization in patients with low preoperative resting P ET CO 2 (<38 mm Hg) and decreasing resting P ET CO 2 after revascularization in patients with high preoperative resting P ET CO 2 (>38 mm Hg). Conclusions This study demonstrates that resting P ET CO 2 in patients with intracranial steno-occlusive disease is highly variable. In some patients, there was a change in resting P ET CO 2 after a revascularization procedure.","PeriodicalId":8521,"journal":{"name":"Asian Journal of Neurosurgery","volume":"356 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Neurosurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0044-1786699","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract Introduction Controlling the partial pressure of carbon dioxide (PaCO 2 ) is an important consideration in patients with intracranial steno-occlusive disease to avoid reductions in critical perfusion from vasoconstriction due to hypocapnia, or reductions in blood flow due to steal physiology during hypercapnia. However, the normal range for resting PCO 2 in this patient population is not known. Therefore, we investigated the variability in resting end-tidal PCO 2 (P ET CO 2 ) in patients with intracranial steno-occlusive disease and the impact of revascularization on resting P ET CO 2 in these patients. Setting and Design Tertiary care center, retrospective chart review Materials and Methods We collected resting P ET CO 2 values in adult patients with intracranial steno-occlusive disease who presented to our institution between January 2010 and June 2021. We also explored postrevascularization changes in resting P ET CO 2 in a subset of patients. Results Two hundred and twenty-seven patients were included [moyamoya vasculopathy ( n = 98) and intracranial atherosclerotic disease ( n = 129)]. In the whole cohort, mean ± standard deviation resting P ET CO 2 was 37.8 ± 3.9 mm Hg (range: 26–47). In patients with moyamoya vasculopathy and intracranial atherosclerotic disease, resting P ET CO 2 was 38.4 ± 3.6 mm Hg (range: 28–47) and 37.4 ± 4.1 mm Hg (range: 26–46), respectively. A trend was identified suggesting increasing resting P ET CO 2 after revascularization in patients with low preoperative resting P ET CO 2 (<38 mm Hg) and decreasing resting P ET CO 2 after revascularization in patients with high preoperative resting P ET CO 2 (>38 mm Hg). Conclusions This study demonstrates that resting P ET CO 2 in patients with intracranial steno-occlusive disease is highly variable. In some patients, there was a change in resting P ET CO 2 after a revascularization procedure.
摘要 引言 控制二氧化碳分压(PaCO 2)是颅内狭窄性闭塞症患者的一个重要考虑因素,以避免因低碳酸血症导致血管收缩而导致临界灌注量减少,或因高碳酸血症期间的盗血生理现象而导致血流量减少。然而,这类患者静息 PCO 2 的正常范围尚不清楚。因此,我们研究了颅内狭窄闭塞症患者静息潮气末 PCO 2(P ET CO 2)的变异性,以及血管再通术对这些患者静息 P ET CO 2 的影响。材料和方法 我们收集了 2010 年 1 月至 2021 年 6 月期间在我院就诊的颅内狭窄闭塞症成年患者的静息 P ET CO 2 值。我们还研究了一部分患者血管重建后静息 P ET CO 2 的变化。结果 共纳入 227 名患者[莫亚莫亚血管病(98 人)和颅内动脉粥样硬化性疾病(129 人)]。在所有患者中,静息 P ET CO 2 的平均值(± 标准差)为 37.8 ± 3.9 mm Hg(范围:26-47)。在患有莫亚莫亚血管病和颅内动脉粥样硬化疾病的患者中,静息 P ET CO 2 分别为 38.4 ± 3.6 mm Hg(范围:28-47)和 37.4 ± 4.1 mm Hg(范围:26-46)。研究发现,术前静息 P ET CO 2 较低(38 毫米汞柱)的患者在血管再通后静息 P ET CO 2 呈上升趋势。结论 本研究表明,颅内狭窄闭塞症患者的静息 P ET CO 2 变化很大。在一些患者中,血管重建术后静息 P ET CO 2 发生了变化。